David Lagorce

5.4k total citations · 1 hit paper
34 papers, 2.6k citations indexed

About

David Lagorce is a scholar working on Molecular Biology, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, David Lagorce has authored 34 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Computational Theory and Mathematics and 8 papers in Pharmacology. Recurrent topics in David Lagorce's work include Computational Drug Discovery Methods (18 papers), Microbial Natural Products and Biosynthesis (8 papers) and Protein Structure and Dynamics (6 papers). David Lagorce is often cited by papers focused on Computational Drug Discovery Methods (18 papers), Microbial Natural Products and Biosynthesis (8 papers) and Protein Structure and Dynamics (6 papers). David Lagorce collaborates with scholars based in France, Italy and United States. David Lagorce's co-authors include Bruno O. Villoutreix, Maria A. Miteva, Olivier Spérandio, Céline M. Labbé, Patrizia Paterlini-Bréchot, Mounia Chami, Christian Bréchot, Jonathan B. Baell, Hervé Galons and Devrim Gözüaçık and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

David Lagorce

33 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery

2017 253 citations David Lagorce, Maria A. Miteva et al. Bioinformatics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Lagorce France	25	1.4k	933	576	417	361	34	2.6k
Khaled Barakat Canada	30	1.4k 1.0×	490 0.5×	212 0.4×	143 0.3×	244 0.7×	115	2.6k
Ralph T. Mosley United States	25	814 0.6×	335 0.4×	167 0.3×	212 0.5×	562 1.6×	43	1.7k
Bertil Samuelsson Sweden	34	1.6k 1.2×	554 0.6×	351 0.6×	385 0.9×	1.6k 4.6×	134	3.6k
Giosuè Costa Italy	30	1.4k 1.0×	220 0.2×	211 0.4×	150 0.4×	388 1.1×	107	2.5k
F. George Njoroge United States	26	853 0.6×	184 0.2×	372 0.6×	648 1.6×	836 2.3×	101	2.5k
Peter Schmidtke Spain	18	2.3k 1.7×	1.1k 1.2×	196 0.3×	38 0.1×	282 0.8×	26	3.2k
Vincenzo Summa Italy	25	857 0.6×	251 0.3×	346 0.6×	392 0.9×	684 1.9×	104	2.2k
Abhinav Grover India	33	1.6k 1.2×	672 0.7×	222 0.4×	33 0.1×	384 1.1×	142	2.9k
Maria Chiara Monti Italy	32	1.1k 0.8×	139 0.1×	444 0.8×	222 0.5×	449 1.2×	134	2.7k
Charles A. Lesburg United States	17	1.1k 0.8×	106 0.1×	336 0.6×	510 1.2×	192 0.5×	34	1.9k

Countries citing papers authored by David Lagorce

Since Specialization

Citations

This map shows the geographic impact of David Lagorce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lagorce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lagorce more than expected).

Fields of papers citing papers by David Lagorce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Lagorce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lagorce. The network helps show where David Lagorce may publish in the future.

Co-authorship network of co-authors of David Lagorce

This figure shows the co-authorship network connecting the top 25 collaborators of David Lagorce. A scholar is included among the top collaborators of David Lagorce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Lagorce. David Lagorce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lagorce, David, Leslie Matalonga, Ida Paramonov, et al.. (2023). Phenotypic similarity-based approach for variant prioritization for unsolved rare disease: a preliminary methodological report. European Journal of Human Genetics. 32(2). 182–189. 5 indexed citations

Bosc, Nicolas, Christophe Müller, Laurent Hoffer, et al.. (2020). Fr-PPIChem: An Academic Compound Library Dedicated to Protein–Protein Interactions. ACS Chemical Biology. 15(6). 1566–1574. 29 indexed citations

Labbé, Céline M., Julien Rey, David Lagorce, et al.. (2015). MTiOpenScreen: a web server for structure-based virtual screening. Nucleic Acids Research. 43(W1). W448–W454. 182 indexed citations

Villoutreix, Bruno O., Mélaine A. Kuenemann, Jean‐Luc Poyet, et al.. (2014). Drug‐Like ProteinProtein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology. Molecular Informatics. 33(6-7). 414–437. 79 indexed citations

Zhang, Zhe, Virginie Martiny, David Lagorce, et al.. (2014). Rational Design of Small-Molecule Stabilizers of Spermine Synthase Dimer by Virtual Screening and Free Energy-Based Approach. PLoS ONE. 9(10). e110884–e110884. 23 indexed citations

Zhang, Zhe, Virginie Martiny, David Lagorce, Emil Alexov, & Maria A. Miteva. (2013). Snyder-Robinson Syndrome: Rescuing the Disease-Causing Effect of G56S mutant by Small Molecule Binding. Bulletin of the American Physical Society. 2013.

Martiny, Virginie, Pablo Carbonell, David Lagorce, et al.. (2013). In Silico Mechanistic Profiling to Probe Small Molecule Binding to Sulfotransferases. PLoS ONE. 8(9). e73587–e73587. 24 indexed citations

Villoutreix, Bruno O., David Lagorce, Céline M. Labbé, Olivier Spérandio, & Maria A. Miteva. (2013). One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade. Drug Discovery Today. 18(21-22). 1081–1089. 60 indexed citations

Villoutreix, Bruno O., Céline M. Labbé, David Lagorce, Guillaume Laconde, & Olivier Spérandio. (2012). A Leap into the Chemical Space of Protein-Protein Interaction Inhibitors. Current Pharmaceutical Design. 18(30). 4648–4667. 57 indexed citations

10.

Villoutreix, Bruno O., Guillaume Laconde, David Lagorce, et al.. (2011). Tyrosine Kinase Syk Non-Enzymatic Inhibitors and Potential Anti-Allergic Drug-Like Compounds Discovered by Virtual and In Vitro Screening. PLoS ONE. 6(6). e21117–e21117. 24 indexed citations

11.

Lagorce, David, Bruno O. Villoutreix, & Maria A. Miteva. (2011). Three-dimensional structure generators of drug-like compounds: DG-AMMOS, an open-source package. Expert Opinion on Drug Discovery. 6(3). 339–351. 7 indexed citations

12.

Pencheva, Tania, David Lagorce, Ilza Pajeva, Bruno O. Villoutreix, & Maria A. Miteva. (2011). AMMOS Software: Method and Application. Methods in molecular biology. 819. 127–141. 1 indexed citations

13.

Lagorce, David, Julien Maupetit, Jonathan B. Baell, et al.. (2011). The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections. Bioinformatics. 27(14). 2018–2020. 77 indexed citations

14.

Villoutreix, Bruno O., Nicolas Renault, David Lagorce, Matthieu Montès, & Maria A. Miteva. (2007). Free Resources to Assist Structure-Based Virtual Ligand Screening Experiments. Current Protein and Peptide Science. 8(4). 381–411. 72 indexed citations

15.

Benali-Furet, Naoual, Mounia Chami, Ludivine Houel‐Renault, et al.. (2005). Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion. Oncogene. 24(31). 4921–4933. 228 indexed citations

16.

Paterlini-Bréchot, Patrizia, Kenichi Saigo, Yoshiki Murakami, et al.. (2003). Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene. 22(25). 3911–3916. 237 indexed citations

17.

Gözüaçık, Devrim, Yoshiki Murakami, Kenichi Saigo, et al.. (2001). Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA tagging. Oncogene. 20(43). 6233–6240. 81 indexed citations

18.

Loriot, Marie‐Anne, Jean–Pierre Bronowicki, David Lagorce, et al.. (1999). Permissiveness of Human Biliary Epithelial Cells to Infection by Hepatitis C Virus. Hepatology. 29(5). 1587–1595. 46 indexed citations

19.

Zylberberg, Hervé, Stanislas Pol, Valérie Thiers, et al.. (1999). Significance of Repeatedly Normal Aminotransferase Activities in HCV-Infected Patients. Journal of Clinical Gastroenterology. 29(1). 71–75. 4 indexed citations

20.

Bréchot, Christian, David Lagorce, Guido Gerken, et al.. (1998). Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. Journal of Hepatology. 29(2). 173–183. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact